Thermally Reconfigurable Interfaces Engineered by Robust Ionogels for Intelligent TENG Signal Modulation. [PDF]
Hou J, Ma H, Wang X, Sun P, Wang F.
europepmc +1 more source
Translating whole‐genome doubling into precision medicine in cancer
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley +1 more source
Communication Signal Modulation Recognition Method Based on Multi-Feature Multi-Channel ResNet and BiLSTM Neural Network. [PDF]
Li X, Geng X, Xu Y, Cao F.
europepmc +1 more source
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
A Broad-Band Self-Powered Photodetector Based on a MoTe<sub>2</sub>/Bi<sub>2</sub>Te<sub>3</sub> Heterojunction for Optical Imaging and Bias-Controlled Signal Modulation. [PDF]
Du S +8 more
europepmc +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics. [PDF]
Furukawa K +7 more
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Radio Signal Modulation Recognition Method Based on Hybrid Feature and Ensemble Learning: For Radar and Jamming Signals. [PDF]
Zhou Y, Cao R, Zhang A, Li P.
europepmc +1 more source
Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. [PDF]
Benelli R +7 more
europepmc +1 more source

